Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,120.10
-55.30 (-2.54%)
Jan 19, 2026, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 898.02 billion as of January 16, 2026. Its market cap has decreased by -24.43% in one year.
Market Cap
898.02B
Enterprise Value
949.14B
Revenue
135.46B
Ranking
n/a
PE Ratio
51.10
Stock Price
2,120.10
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 898.02B, an increase of 57.61%. That is a compound annual growth rate of 18.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 873.99B | -3.61% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.00T |
| Divi's Laboratories | 1.66T |
| Cipla | 1.13T |
| Apollo Hospitals Enterprise | 1.04T |
| Zydus Lifesciences | 873.51B |
| Alkem Laboratories | 697.84B |
| Aurobindo Pharma | 681.11B |
| Fortis Healthcare | 676.78B |